We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

Back to rankings

113 hedge funds and large institutions have $424M invested in Five Prime Therapeutics, Inc. in 2019 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 30 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more capital invested

Capital invested by funds: $287M → $424M (+$137M)

30% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 30

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less funds holding

Funds holding: 116 → 113 (-3)

17% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 18

35% less call options, than puts

Call options by funds: $1.35M | Put options by funds: $2.09M

Holders
113
Holders Change
-3
Holders Change %
-2.59%
% of All Funds
2.45%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
39
Reduced
30
Closed
18
Calls
$1.35M
Puts
$2.09M
Net Calls
-$740K
Net Calls Change
-$38K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$7.42M
2
AC
Armistice Capital
New York
+$3.42M
3
BI
BVF Inc
California
+$3.23M
4
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale
Germany
+$3.11M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$2.85M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$3.04M
2
SI
Sofinnova Investments
California
-$2.93M
3
BlackRock
BlackRock
New York
-$2.52M
4
Millennium Management
Millennium Management
New York
-$1.84M
5
AllianceBernstein
AllianceBernstein
Tennessee
-$1.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fifth Third Bancorp
101
Fifth Third Bancorp
Ohio
$4K – – –
Nisa Investment Advisors
102
Nisa Investment Advisors
Missouri
$4K – – –
WT
103
Whittier Trust
California
$4K – – –
LTFS
104
Ladenburg Thalmann Financial Services
Florida
$4K +$3.42K +300 New
TRCT
105
Tower Research Capital (TRC)
New York
$4K +$3.42K +300 New
APA
106
American Portfolios Advisors
New York
$3.35K – – –
IUHSA
107
Itau Unibanco Holding S.A.
Brazil
$3K – – –
SWM
108
SeaCrest Wealth Management
New York
$3K – – –
Daiwa Securities Group
109
Daiwa Securities Group
Japan
$2K – – –
PNC Financial Services Group
110
PNC Financial Services Group
Pennsylvania
$2K +$1.82K +160 +640%
PA
111
Parallel Advisors
California
$1K +$1.06K +93 New
GT
112
Glenmede Trust
Pennsylvania
$3 – – –
EC
113
EcoR1 Capital
California
– -$3.04M -326,775 Closed
SI
114
Sofinnova Investments
California
– -$2.93M -315,344 Closed
Millennium Management
115
Millennium Management
New York
– -$1.84M -198,171 Closed
Walleye Trading
116
Walleye Trading
New York
– -$543K -58,340 Closed
TI
117
Trexquant Investment
Connecticut
– -$332K -35,716 Closed
SCA
118
Secor Capital Advisors
New York
– -$151K -16,215 Closed
DTL
119
Dynamic Technology Lab
Singapore
– -$123K -13,241 Closed
FRM
120
Fox Run Management
Connecticut
– -$113K -12,132 Closed
VF
121
Virtu Financial
New York
– -$113K -12,105 Closed
Jane Street
122
Jane Street
New York
– -$110K -11,870 Closed
XK
123
Xact Kapitalforvaltning
Sweden
– -$97K -10,444 Closed
QT
124
Quantamental Technologies
New York
– -$58K -6,280 Closed
Bank of Montreal
125
Bank of Montreal
Ontario, Canada
– -$11K -1,248 Closed
2 3 4
5
6

FPRX Hedge Fund Activity: Q1 2019 in Review

113 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q1 2019, worth a combined $424M — up 48% from $287M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of FPRX and 15 opened new positions — a net loss of 3 holders — while 30 trimmed existing stakes and 39 added.

The largest buyer was Vanguard Group, adding an estimated $7.42M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $3.04M sold.

  • 113 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q1 2019, down from 116 in Q4 2018.
  • Funds reported $424M of Five Prime Therapeutics, Inc. stock for Q1 2019, up 48% quarter-over-quarter.
  • 15 funds opened new Five Prime Therapeutics, Inc. positions in Q1 2019 and 18 closed out, a net change of -3 holders.
  • The largest Five Prime Therapeutics, Inc. buyer in Q1 2019 was Vanguard Group, an estimated $7.42M added.
  • The largest Five Prime Therapeutics, Inc. seller in Q1 2019 was EcoR1 Capital, an estimated $3.04M sold.

Based on aggregated 13F filings for Q1 2019.